Tag: biotechnology
-
Biotechs Partner on Antibody, T-Cell Cancer Therapies in $100M Deal
Two biotechnology companies with complementary technologies plan to create treatments for cancer that harness and modify cells from the immune system delivered with benign viruses.
-
Engineered Bacteria Studied for Rare Inherited Skin Disorder
A biotechnology company and research lab are evaluating a modified skin bacteria as a treatment for Netherton syndrome, a rare inherited skin disease affecting mainly infants and young children.
-
Trial Shows Antibiotic More Effective Against Crohn’s Disease
Early results from a clinical trial show an experimental antibiotic drug helps more people achieve remission of their Crohn’s disease for longer periods than a similar group given a placebo.
-
NIH Small Business Grant Funds Severe Hepatitis Treatment
A biotechnology company is developing treatments for a severe form of hepatitis, which up to now has only limited therapy options, with a synthetic form of RNA designed to shut down the infecting virus.
-
Drug Discovery System Designed to Identify Difficult Targets
A lab in the U.K. developed a system for discovering new therapies that identify therapy targets linked to enzymes, some found in neurodegenerative diseases, previously considered too difficult to address.
-
Experimental Drug Extends Survival, Reverses Inherited ALS Damage
An experimental drug designed to silence a protein associated with inherited forms of amyotrophic lateral sclerosis, or ALS, is shown in tests with lab rodents to extend survival and reverse some neuromuscular damage.
-
BASF, UC-Davis Partner on Human Milk Sugars
BASF and a research institute at University of California in Davis are investigating complex sugars found in human breast milk, and their role in maintaining healthy gut microbes.
-
Merck, Biopharma Partner on Cell-Free Immune System Therapies
Drug maker Merck is acquiring the rights to therapies for cancer and autoimmune disorders based on a technology for developing synthetic proteins from a process that bypasses live cells.
-
NSF, Industry Group Fund Bio-Based Semiconductor R&D
A research consortium in the semiconductor industry and National Science Foundation are supporting a series of projects investigating interactions between biology and circuits for data transfer and storage.
-
More Damage Detected from Crispr-Cas9 Edits
A genetics lab in the U.K. revealed that a leading technique for editing genomes produces more unwanted damage to the edited genomes than previously understood.